| 000 | 01837 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514011150.0 | ||
| 264 | 0 | _c20020308 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a1524-9557 | ||
| 024 | 7 |
_a10.1097/00002371-200107000-00014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFoncuberta, M C | |
| 245 | 0 | 0 |
_aTopical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors. _h[electronic resource] |
| 260 |
_bJournal of immunotherapy (Hagerstown, Md. : 1997) _c |
||
| 300 |
_a384-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMouth Mucosa _xdrug effects |
| 650 | 0 | 4 | _aMouthwashes |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xadministration & dosage |
| 700 | 1 | _aCagnoni, P J | |
| 700 | 1 | _aBrandts, C H | |
| 700 | 1 | _aMandanas, R | |
| 700 | 1 | _aFields, K | |
| 700 | 1 | _aDerigs, H G | |
| 700 | 1 | _aReed, E | |
| 700 | 1 | _aSonis, S T | |
| 700 | 1 | _aFay, J | |
| 700 | 1 | _aLeVeque, F | |
| 700 | 1 | _aPouillart, P | |
| 700 | 1 | _aSchrezenmeier, H | |
| 700 | 1 | _aEmmons, R | |
| 700 | 1 | _aThiel, E | |
| 773 | 0 |
_tJournal of immunotherapy (Hagerstown, Md. : 1997) _gvol. 24 _gno. 4 _gp. 384-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002371-200107000-00014 _zAvailable from publisher's website |
| 999 |
_c11487843 _d11487843 |
||